143 related articles for article (PubMed ID: 12642867)
21. Signal transducers and activators of transcription 5B potentiates v-Src-mediated transformation of NIH-3T3 cells.
Kazansky AV; Rosen JM
Cell Growth Differ; 2001 Jan; 12(1):1-7. PubMed ID: 11205741
[TBL] [Abstract][Full Text] [Related]
22. Differential roles for signal transducers and activators of transcription 5a and 5b in PRL stimulation of ERalpha and ERbeta transcription.
Frasor J; Park K; Byers M; Telleria C; Kitamura T; Yu-Lee LY; Djiane J; Park-Sarge OK; Gibori G
Mol Endocrinol; 2001 Dec; 15(12):2172-81. PubMed ID: 11731618
[TBL] [Abstract][Full Text] [Related]
23. Co-overexpression of Janus kinase 2 and signal transducer and activator of transcription 5a promotes differentiation of mammary cancer cells through reversal of epithelial-mesenchymal transition.
Sultan AS; Brim H; Sherif ZA
Cancer Sci; 2008 Feb; 99(2):272-9. PubMed ID: 18271926
[TBL] [Abstract][Full Text] [Related]
24. A constitutively active Lck kinase promotes cell proliferation and resistance to apoptosis through signal transducer and activator of transcription 5b activation.
Shi M; Cooper JC; Yu CL
Mol Cancer Res; 2006 Jan; 4(1):39-45. PubMed ID: 16446405
[TBL] [Abstract][Full Text] [Related]
25. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
Song L; Turkson J; Karras JG; Jove R; Haura EB
Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the human STAT5A and STAT5B promoters: evidence of a positive and negative mechanism of transcriptional regulation.
Crispi S; Sanzari E; Monfregola J; De Felice N; Fimiani G; Ambrosio R; D'Urso M; Ursini MV
FEBS Lett; 2004 Mar; 562(1-3):27-34. PubMed ID: 15043997
[TBL] [Abstract][Full Text] [Related]
27. EGF receptor-mediated, c-Src-dependent, activation of Stat5b is downregulated in mitogenically responsive hepatocytes.
Guren TK; Ødegård J; Abrahamsen H; Thoresen GH; Susa M; Andersson Y; Østby E; Christoffersen T
J Cell Physiol; 2003 Jul; 196(1):113-23. PubMed ID: 12767047
[TBL] [Abstract][Full Text] [Related]
28. Glucocorticoid receptor/signal transducer and activator of transcription 5 (STAT5) interactions enhance STAT5 activation by prolonging STAT5 DNA binding and tyrosine phosphorylation.
Wyszomierski SL; Yeh J; Rosen JM
Mol Endocrinol; 1999 Feb; 13(2):330-43. PubMed ID: 9973262
[TBL] [Abstract][Full Text] [Related]
29. Overexpression and constitutive activation of FLT3 induces STAT5 activation in primary acute myeloid leukemia blast cells.
Spiekermann K; Bagrintseva K; Schwab R; Schmieja K; Hiddemann W
Clin Cancer Res; 2003 Jun; 9(6):2140-50. PubMed ID: 12796379
[TBL] [Abstract][Full Text] [Related]
30. Expression of a carboxy terminally truncated Stat5 with no transactivation domain in the mammary glands of transgenic mice inhibits cell proliferation during pregnancy, delays onset of milk secretion, and induces apoptosis upon involution.
Iavnilovitch E; Eilon T; Groner B; Barash I
Mol Reprod Dev; 2006 Jul; 73(7):841-9. PubMed ID: 16596634
[TBL] [Abstract][Full Text] [Related]
31. Stimulation of estrogen receptor signaling by gamma synuclein.
Jiang Y; Liu YE; Lu A; Gupta A; Goldberg ID; Liu J; Shi YE
Cancer Res; 2003 Jul; 63(14):3899-903. PubMed ID: 12873981
[TBL] [Abstract][Full Text] [Related]
32. Loss of Stat5a delays mammary cancer progression in a mouse model.
Ren S; Cai HR; Li M; Furth PA
Oncogene; 2002 Jun; 21(27):4335-9. PubMed ID: 12082622
[TBL] [Abstract][Full Text] [Related]
33. CPAP is a novel stat5-interacting cofactor that augments stat5-mediated transcriptional activity.
Peng B; Sutherland KD; Sum EY; Olayioye M; Wittlin S; Tang TK; Lindeman GJ; Visvader JE
Mol Endocrinol; 2002 Sep; 16(9):2019-33. PubMed ID: 12198240
[TBL] [Abstract][Full Text] [Related]
34. Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice.
Levy DE; Gilliland DG
Oncogene; 2000 May; 19(21):2505-10. PubMed ID: 10851049
[TBL] [Abstract][Full Text] [Related]
35. Naturally occurring dominant negative variants of Stat5.
Wang D; Stravopodis D; Teglund S; Kitazawa J; Ihle JN
Mol Cell Biol; 1996 Nov; 16(11):6141-8. PubMed ID: 8887644
[TBL] [Abstract][Full Text] [Related]
36. Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype.
Moriggl R; Gouilleux-Gruart V; Jähne R; Berchtold S; Gartmann C; Liu X; Hennighausen L; Sotiropoulos A; Groner B; Gouilleux F
Mol Cell Biol; 1996 Oct; 16(10):5691-700. PubMed ID: 8816482
[TBL] [Abstract][Full Text] [Related]
37. A constitutively active ERBB4/HER4 allele with enhanced transcriptional coactivation and cell-killing activities.
Vidal GA; Clark DE; Marrero L; Jones FE
Oncogene; 2007 Jan; 26(3):462-6. PubMed ID: 16832345
[TBL] [Abstract][Full Text] [Related]
38. Cross-talk between ERs and signal transducer and activator of transcription 5 is E2 dependent and involves two functionally separate mechanisms.
Faulds MH; Pettersson K; Gustafsson JA; Haldosén LA
Mol Endocrinol; 2001 Nov; 15(11):1929-40. PubMed ID: 11682624
[TBL] [Abstract][Full Text] [Related]
39. Regulated expression of signal transducer and activator of transcription, Stat5, and its enhancement of PRL expression in human endometrial stromal cells in vitro.
Mak IY; Brosens JJ; Christian M; Hills FA; Chamley L; Regan L; White JO
J Clin Endocrinol Metab; 2002 Jun; 87(6):2581-8. PubMed ID: 12050218
[TBL] [Abstract][Full Text] [Related]
40. Signal transducer and activator of transcription 5a (STAT5a) is required for eosinophil differentiation of human cord blood-derived CD34+ cells.
Buitenhuis M; Baltus B; Lammers JW; Coffer PJ; Koenderman L
Blood; 2003 Jan; 101(1):134-42. PubMed ID: 12393707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
